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The objective of this analysis is to compare people with prevalent type 2 diabetes, incident
type 2 diabetes and without diabetes with respect to longitudinal change in health-related
quality of life (HRQOL) when adjusting for baseline determinants of HRQOL.
Research design and methods
Primary baseline and follow-up data from three regional and one national population-based
cohort studies in Germany were pooled for analysis. HRQOL was measured using physical
and mental health summary scores (PCS and MCS) from the German version of the Short
Form Health Survey with 36 or 12 items. Mean score change per observation year was com-
pared between the three groups (prevalent diabetes, incident diabetes, no diabetes) based
on linear regression models.
Results
The analysis included pooled data from 5367 people aged 45–74 years at baseline. Of
these, 85.5% reported no diabetes at baseline and follow-up, 6.3% reported diabetes at
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both baseline and follow-up (prevalent diabetes), and 8.2% reported diabetes only at follow-
up (incident diabetes). Over a mean observation period of 8.7 years, annual decline in
HRQOL scores is pronounced at 0.27–0.32 (PCS) and 0.34–0.38 (MCS) in the group with
prevalent diabetes compared with people without diabetes. Those with incident diabetes
showed intermediate values but did not differ significantly from people without diabetes after
adjustment for covariates in the full model.
Conclusion
Compared with data from cross-sectional analysis, the HRQOL loss associated with preva-
lent diabetes appears to be much larger than previously assumed.
Introduction
Health-related quality of life (HRQOL) is a central parameter for assessment of the burden of
illness as well as the clinical effectiveness of care and treatment. Estimations of the impact of
type 2 diabetes on HRQOL underline the significant burden of this complex disease with its
correlates in terms of lifestyle factors, comorbidities, and diabetes complications. In popula-
tion-based, cross-sectional studies, HRQOL measured with generic instruments such as the
EQ-5D or the Short Form Health Survey with 36 or 12 items (SF-36/12) has been found to be
at least moderately impaired in people with diabetes compared with people without diabetes
[1, 2]. Studies using the SF-36/12, which measures different domains of physical and mental
HRQOL, found the impairment in the physical health summary score (PCS) to be much larger
than that in the mental health summary score (MCS) [3–6]. Effect sizes with regard to the PCS
are considered to be clinically relevant [7]. The main drivers of the HRQOL detriment associ-
ated with diabetes are comorbidities and complications [8–12].
Longitudinal analysis adds to an understanding of the variation in HRQOL over time, but
data are scarce compared with cross-sectional data. To the best of our knowledge, only three
previous studies had a longitudinal design. One is a US-based survey study that used the EQ-
5D as a measurement for health status and collected data in 2004 and 2009 [13]. The decline in
EQ-5D index scores in people with diabetes was significantly greater and twice the size com-
pared with people without diabetes. The other two studies are not population-based and do
not include people without diabetes [14, 15]. Bayliss et al. analyzed the Medical Outcome
Study data from the early 1990s and compared the impact of diabetes on HRQOL with other
chronic diseases measured over 4 years [14]. Diabetes increased the odds of a decline in SF-36
PCS scores to a greater degree than other diseases except for congestive heart failure. The most
recent longitudinal study, undertaken with a practice-based sample in Germany between 2000
and 2007, analyzed changes in HRQOL among general practice patients with diabetes [15]. It
underlined the impact of diabetes-related complications and comorbidities on lower HRQOL
scores at follow-up after 5 years. These studies suggest the benefits of longitudinal data to eluci-
date the true burden of diabetes, but further studies including a control group and with longer
time horizons are needed to get a valid estimate of this burden.
In this study, we analyze a large dataset with pooled data from four population-based cohort
studies in Germany to measure the impact of diabetes on HRQOL over an observation time of
5–12 years. The objective of this analysis is to compare people with prevalent diabetes and
those with incident diabetes with people without diabetes with respect to longitudinal change
in HRQOL when adjusting for baseline determinants of HRQOL.
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Research design and methods
Study design
Baseline and follow-up data from three regional and one national population-based cohort
studies were included in this analysis: the Cooperative Health Research in the Region of Augs-
burg (KORA) study; the Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study;
the Study of Health in Pomerania (SHIP); and the nationwide German National Health Inter-
view and Examination Survey (baseline: GNHIES98; follow-up: DEGS1) carried out by the
Robert Koch Institute (RKI). Data collection for baseline studies was performed between 1997
and 2006 and for follow-up examinations between 2006 and 2012 (Table 1).
Participants
Study details have been described elsewhere [16–22]. All included studies are population-based
cohort studies comparable with regard to study design, sampling methods, and response rates.
All studies carried out baseline and follow-up assessments in local study centers, where partici-
pants were examined, laboratory testing material was collected, and standardized computer-
assisted clinical medical interviews (CAPI) were conducted. In addition, participants filled in
self-administered questionnaires. All participants gave written informed consent. All studies
were approved by local ethics committees and monitored by external quality assurance boards.
Type 2 diabetes is defined based on self-report of physician-diagnosed diabetes mellitus or
self-reported intake of oral anti-diabetic agents or insulin. Participants with an age of onset
of 30 years were excluded, assuming they had type 1 diabetes. Participants with missing infor-
mation on diabetes were included when they self-reported the intake of oral anti-diabetic agents
but excluded when they reported the intake of insulin, again to reduce the risk of including par-
ticipants with type 1 diabetes. Following this definition, participants with type 2 diabetes at nei-
ther baseline nor follow-up were classified as “no diabetes”; those with type 2 diabetes at both
baseline and follow-up were classified as “prevalent diabetes”. Participants with type 2 diabetes
only at follow-up were classified as “incident diabetes”. To ensure comparability between stud-
ies, analyses were restricted to participants aged between 45 and 74 years at baseline. Only par-
ticipants with data from both baseline and follow-up were included in this study.
The flowchart of the sample by diabetes status and study is illustrated in Fig 1.
Variables
The outcome variable in this study is HRQOL, as measured with a generic instrument, the
German version of the Short Form Health Survey with 36 or 12 items (SF-36/12) [23]. This
Table 1. Studies included in the pooled analysis.
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instrument was applied across all studies as a self-administered questionnaire, except for the
KORA baseline study where it was part of the clinical medical interview. Two SF12/36 sum-
mary scores will be used for this analysis: the physical component summary (PCS) and the
mental component summary (MCS). KORA, SHIP, and CARLA used version 1 of the SF-12
(SF-12v1) in baseline and follow-up studies; the GNHIES98 survey used version 1 of the SF-36
(SF-36v1), but DEGS1 used version 2 (SF-36v2) [24]. Scores are calculated using standard
algorithms [25]. As reported in the literature, SF-12v1 and SF-36v1 summary scores express a
high degree of correspondence [25, 26]. To compare the summary scores across studies, we
used the US 1998 norm data and transformed the SF36v2 values to SF36vs1 values, as allowed
for in the scoring software [27]. Both scores are transformed to a mean of 50 and standard
deviation of 10, with higher values indicating better HRQOL.
Fig 1. Flowchart of sample.
https://doi.org/10.1371/journal.pone.0176895.g001
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Other variables that were controlled for included age (in years), sex, and study. Furthermore,
socioeconomic information, comorbidities, and lifestyle variables assessed at baseline were
included. Education was treated as a dichotomous variable with two levels (< 10 years vs. 10
years). Income was transformed to equivalent income and categorized with reference to the
median income of the GNHIES98 study, irrespective of when the baseline assessment took place
exactly in each study. Living alone (yes vs. no) was based on information regarding household
size. Information on comorbidities followed survey questions if myocardial infarction or stroke
had ever been diagnosed or treated in hospital, and if a doctor had ever diagnosed hypertension
or hyperlipidemia. Weight and height were measured at the study center and calculated as body
mass index (BMI; weight in kilograms divided by the squared height in meters), classified in six
groups according to the WHO (underweight: BMI<18.5 kg/m2; normal weight: 18.5BMI<25;
pre-obesity: 25BMI<30; moderate obesity (i.e., obesity class 1): 30BMI<35; severe obesity
(i.e., obesity class 2): 35BMI<40; very severe obesity (i.e., obesity class 3): BMI40 kg/m2) [28].
Lifestyle variables included physical activity (<1 hour per week vs. more), alcohol consumption
(>40g/day for men;>20g/day for women vs. less), and smoking (current vs. formerly or never).
Primary data from the studies were added to a joint database. All variables were recoded
following standard procedures, established jointly with co-workers from the DIAB-CORE
consortium [29–31].
Missing values
Participants with any missing values in the SF-12 items were excluded because the calculation
of summary scores is not possible in this case, following the recommendations of the in-
strument’s authors [25]. Exclusions applied to N = 136 (KORA, 7.7% of sample), N = 118
(CARLA; 10.0% of sample), and N = 191 (SHIP, 15.8% of sample). In studies that used the
SF-36, participants were excluded only when missing values did not allow for calculation of
the subscales [32] (N = 244, RKI; 12.9% of sample). Taken together, N = 689 (11.4%) of the
pooled sample were excluded due to missing values in the SF-12v1 and SF-36v1. Final sample
size for the analysis was N = 5367 (Table 2 and Fig 1). Participants with missing values in co-
variates were excluded (N = 65) in the respective regression models.
Statistical analysis
Descriptive statistics of the sample were reported separately for those with prevalent diabetes,
incident diabetes, and without diabetes. To examine the diabetes-related impact on the course
of HRQOL, the absolute change in PCS or MCS scores per observation year (difference be-
tween the baseline and follow-up score divided by the time difference between both examina-
tion time points) was chosen as the main analysis parameter. Comparisons between the three
groups (prevalent diabetes, incident diabetes, no diabetes) were done by contrasts based on
linear regression models. We first used a crude regression model with adjustment for age,
sex, and study (model 1). In a second model we additionally adjusted for baseline values of
covariates such as socioeconomic variables (school, income), living alone, smoking, alcohol
consumption, physical activity, and BMI (model 2), and in a third model also comorbidities
such as myocardial infarction, stroke, hypertension and hypercholesterolemia were included
(model 3). All models were applied separately to PCS and MCS.
All estimates were reported with 95% confidence intervals (95%CI). Statistical significance
was assumed with P-values less than 0.05. All analyses were performed using SAS statistical
software version 9.3. (SAS Institute, Cary, NC, USA).
Furthermore, we performed several sensitivity analyses. Interactions between diabetes status
and sex, the impact of adjusting the models for baseline PCS and baseline MCS, respectively, and
Longitudinal change of HRQOL in type 2 diabetes
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whether coding of age as a categorical variable leads to differences in the size and direction of
changes in scores were tested.
Results
Participants
The analysis includes pooled data from 5367 people aged 45–74 years at baseline from three
regional population-based cohort studies in Germany, N = 1641 (30.6%) in the South (KORA),
1016 (18.9%) in the North (SHIP), and 1059 (19.7%) in the North-east (CARLA), as well as
1651 (30.8%) from a national cohort study (GNHIES98/DEGS1; RKI). Of these, 85.5% report
no diabetes at baseline and follow-up, 6.3% report diabetes at both baseline and follow-up (prev-
alent diabetes), and 8.2% report diabetes only at follow-up (incident diabetes). Studies differ in
the proportion of participants with prevalent, incident and no diabetes. A greater proportion of
participants were classified with prevalent diabetes in the CARLA study and with incident
Table 2. Sample description.
No diabetes Incident diabetes Prevalent diabetes Total
N 4588 (85.5) 441 (8.2) 338 (6.3) 5367 (100.0)
Sex, female (%) 50.9 45.8 41.7 49.9
Age at baseline (years, mean (SD)) 56.8 (7.7) 58.4 (7.6) 60.7 (7.1) 57.2 (7.7)
Study
KORA 1471 (32.1) 99 (22.4) 71 (21.0) 1641 (30.6)
CARLA 885 (19.3) 61 (13.8) 113 (33.4) 1059 (19.7)
SHIP 833 (18.2) 109 (24.7) 74 (21.9) 1016 (18.9)
RKI 1399 (30.5) 172 (39.0) 80 (23.7) 1651 (30.8)
HRQOL baseline
PCS 48.5 (8.9) 46.7 (9.1) 44.2 (10.0) 48.1 (9.1)
MCS 51.9 (8.9) 52.3 (9.1) 51.6 (10.4) 51.9 (9.0)
Education (<10 years) 2457 (53.6) 281 (63.7) 233 (68.9) 2971 (55.4)
Equivalent income of GNHIES 98 median income
less than 60% 437 (9.5) 45 (10.2) 35 (10.4) 517 (9.6)
between median income and 60% 1265 (27.6) 148 (33.6) 126 (37.3) 1539 (28.7)
between median income and 150% 1553 (33.8) 143 (32.4) 118 (34.9) 1814 (33.8)
more than 150% above 975 (21.3) 62 (14.1) 39 (11.5) 1076 (20.0)
Living alone 715 (15.6) 66 (15.0) 59 (17.5) 840 (15.7)
Smoking (current) 875 (19.1) 110 (24.9) 50 (14.8) 1035 (19.3)
Alcohol (>40g/day ♂; >20g/day ♀) 576 (12.6) 50 (11.3) 22 (6.5) 648 (12.1)
Physical activity (less than 1 hour/week) 2057 (44.8) 255 (57.8) 214 (63.3) 2526 (47.1)
BMI group
BMI <18.5 kg/m2 7 (0.2) 0 (0.0) 0 (0.0) 7 (0.1)
BMI18.5 and24.9 kg/m2 1285 (28.0) 32 (7.3) 24 (7.1) 1341 (25.0)
BMI25.0 and29.9 kg/m2 2223 (48.5) 161 (36.5) 127 (37.6) 2511 (46.8)
BMI30.0 and34.9 kg/m2 847 (18.5) 163 (37.0) 117 (34.6) 1127 (21.0)
BMI35.0 and39.9 kg/m2 176 (3.8) 57 (12.9) 52 (15.4) 285 (5.3)
BMI40.0 kg/m2 46 (1.0) 26 (5.9) 17 (5.0) 89 (1.7)
Myocardial infarction 126 (2.7) 21 (4.8) 27 (8.0) 174 (3.2)
Stroke 70 (1.5) 14 (3.2) 16 (4.7) 100 (1.9)
Hypertension 1755 (38.3) 269 (61.0) 240 (71.0) 2264 (42.2)
Hyperlipidemia 1348 (29.4) 195 (44.2) 155 (45.9) 1698 (31.6)
https://doi.org/10.1371/journal.pone.0176895.t002
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diabetes in the DEGS1study, compared with the other studies. Generally, the two studies with
longer follow-up times (SHIP, 11 years; GNHIES98/DEGS1, 12 years) contribute more incident
cases than the studies with shorter follow-up times. Mean follow-up time is 8.7 years (min. 3.4
years; max. 14.2 years) for participants with no diabetes, 9.6 years (min. 3.7 years; max. 14.3
years) for participants with incident diabetes, and 8.1 years (min. 3.8 years; max. 14.1 years) for
participants with prevalent diabetes.
Descriptive data on variables of interest at baseline in total and by diabetes subgroup are
shown in Table 2.
Main results
Compared to mean score changes among adults without diabetes as the reference group, sig-
nificantly larger declines in mean PCS scores are observed among adults with prevalent as
well as among those with incident diabetes (Table 3, model 1). Mean score change in PCS per
observation year, adjusted for age and study, as shown in Fig 2, is –0.22 (–0.26; –0.18) points, –
0.38 (–0.50; –0.25) points, and –0.53 (–0.67; –0.39) points for the groups without diabetes, inci-
dent diabetes, and prevalent diabetes respectively. For MCS, the corresponding Figs are –0.06
(–0.10; 0.01), –0.18 (–0.33; –0.04), and –0.43 (–0.60; –0.27).
Differences in mean score changes are statistically significant for prevalent diabetes vs. no
diabetes for PCS and MCS (both P-values <0.0001), as well as between incident diabetes and
no diabetes for PCS (P-value 0.018), and between incident diabetes and prevalent diabetes for
MCS (P-value 0.024). Significantly larger declines in mean MCS scores compared to the refer-
ence group were restricted to persons with prevalent diabetes. Changes in mean MCS scores
significantly differed between incident diabetes and prevalent diabetes.
Results relating to the comparison of persons with and without diabetes at baseline largely
persisted when additionally controlling for socioeconomic differences and lifestyle variables
and comorbidities (Table 3, model 2 and model 3). In contrast, differences in mean change of
PCS scores between persons with incident diabetes and the reference groups were explained in
models adjusting for additional covariables.
Mean summary scores in PCS and MCS decreased with increasing age (Table 3). MCS
scores are associated with study effects, with the SHIP study displaying less change per annum
than the other studies. Living alone, smoking, obesity, and myocardial infarction is associated
with even larger negative annual changes in PCS scores. No risk factors are associated with
MCS scores except for living alone, showing a positive relationship. Thus, living alone is
reversely related to PCS and MCS scores.
Sensitivity analyses
Interactions between diabetes status and sex were tested but showed no association with
change in HRQOL. Categorization of the variable age did not influence the results. In a sensi-
tivity analysis, we adjusted for baseline PCS and MCS scores in the regression models. This led
to even more pronounced effects of diabetes on change scores in the same direction. An addi-
tional analysis stratified by study showed no heterogeneity in the effect of diabetes status on
annual change in PCS and MCS.
Discussion
This analysis shows that, in longitudinal perspective over a mean observation time of 8.7 years,
annual decline in HRQOL scores in the group with prevalent diabetes is pronounced at 0.53
(PCS) and 0.43 (MCS) and significantly larger than in people without diabetes. Those with
incident diabetes showed intermediate values but did not differ significantly from people
Longitudinal change of HRQOL in type 2 diabetes
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Table 3. Regression models for annual change in HRQOL scores.
Variables Physical component summary score (PCS) Mental component summary score (MCS)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
N = 5367 N = 5302 N = 5302 N = 5367 N = 5302 N = 5302
Diabetes No diabetes Ref. Ref. Ref. Ref. Ref. Ref.
Prevalent diabetes –0.32 –0.27 –0.27 –0.38 –0.35 –0.34
–0.46 to –
0.17
–0.43 to –0.12 –0.43 to –0.12 –0.55 to –
0.21
–0.52 to –0.17 –0.52 to –0.16
Incident diabetes –0.16 –0.11 –0.11 –0.13 –0.07 –0.07
–0.29 to –
0.03
–0.25 to 0.03 –0.25 to 0.02 –0.28 to 0.02 –0.23 to 0.08 –0.23 to 0.09













Sex (Ref. male) Female 0.05 0.07 0.05 0.02 0.02 0.02
–0.02 to 0.12 –0.01 to 0.14 –0.02 to 0.13 –0.06 to 0.10 –0.07 to 0.10 –0.07 to 0.10
Study RKI Ref. Ref. Ref. Ref. Ref. Ref.
CARLA –0.09 –0.10 –0.10 –0.11 –0.13 –0.12
–0.19 to 0.02 –0.21 to 0.01 –0.22 to 0.01 –0.23 to 0.01 –0.25 to 0.00 –0.24 to 0.01
KORA 0.08 0.06 0.07 0.07 0.06 0.07
–0.01 to 0.17 –0.03 to 0.16 –0.03 to 0.17 –0.03 to 0.18 –0.05 to 0.17 –0.05 to 0.18
SHIP 0.05 0.04 0.04 0.21 0.22 0.23
–0.06 to 0.15 –0.07 to 0.15 –0.07 to 0.15 0.09 to 0.33 0.10 to 0.34 0.10 to 0.35








Equivalent income (of GNHIES
98 median income)





















Less than 60% –0.15 –0.14 –0.16 –0.16
–0.30 to 0.01 –0.29 to 0.02 –0.34 to 0.01 –0.33 to 0.01
Living alone –0.13 –0.14 0.18 0.17
(Ref.: no) –0.23 to –0.02 –0.24 to –0.03 0.06 to 0.30 0.05 to 0.30
Smoking (Ref.: formerly or
never)
Current –0.10 –0.10 –0.01 –0.01
–0.19 to 0.00 –0.19 to 0.00 –0.12 to 0.10 –0.12 to 0.10
Alcohol (Ref.: less) >40g/day ♂; –0.08 –0.08 –0.09 –0.09
>20g/day ♀ –0.19 to 0.03 –0.20 to 0.03 –0.22 to 0.04 –0.22 to 0.04








BMI group <18.5 kg/m2 0.27 0.27 0.04 0.05
–0.72 to 1.26 –0.72 to 1.26 –1.09 to 1.17 –1.08 to 1.18
18.5 and24.9 kg/
m2
Ref. Ref. Ref. Ref.
25.0 and29.9 kg/
m2
–0.04 –0.05 0.02 0.02
–0.13 to 0.05 –0.14 to 0.05 –0.09 to 0.12 –0.09 to 0.12
30.0 and34.9 kg/
m2
–0.17 –0.17 –0.12 –0.11
–0.28 to –0.06 –0.28 to –0.06 –0.25 to 0.01 –0.24 to 0.02
35.0 and39.9 kg/
m2
–0.01 –0.01 –0.11 –0.10
(Continued )
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without diabetes after adjustment for covariates in the full model. Effect sizes remain stable
when adjusting for socioeconomic differences and risk factors as well as comorbidities. Living
alone, smoking, obesity, and a history of myocardial infarction are associated with more pro-
nounced decline in PCS scores.
The only other longitudinal study comparing people with and without diabetes used the
EQ-5D index score, but similarly found the decline in people with diabetes to be twice the size
of the decline in people without diabetes over a measurement period of 5 years [13]. Unlike
our analysis, Grandy et al. did not control for comorbidities and risk factors. However, our
data using the SF-12 as a generic HRQOL instrument confirm these results. Both EQ-5D and
Table 3. (Continued)
Variables Physical component summary score (PCS) Mental component summary score (MCS)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
N = 5367 N = 5302 N = 5302 N = 5367 N = 5302 N = 5302
–0.18 to 0.17 –0.19 to 0.17 –0.31 to 0.09 –0.30 to 0.11
40.0 kg/m2 –0.47 –0.47 –0.12 –0.10
–0.76 to –0.18 –0.76 to –0.18 –0.45 to 0.22 –0.43 to 0.23
Myocardial infarction –0.30 –0.09
–0.51 to –0.09 –0.33 to 0.14
Stroke –0.01 –0.03
–0.28 to 0.26 –0.34 to 0.27
Hypertension 0.01 –0.05
–0.07 to 0.09 –0.14 to 0.04
Hyperlipid-emia 0.06 0.04
–0.02 to 0.14 –0.05 to 0.13
Bold-faced numbers are statistically significant with nominal P<0.05.
https://doi.org/10.1371/journal.pone.0176895.t003
Fig 2. Mean score change per observation year, adjusted for age, sex and study.
https://doi.org/10.1371/journal.pone.0176895.g002
Longitudinal change of HRQOL in type 2 diabetes
PLOS ONE | https://doi.org/10.1371/journal.pone.0176895 May 3, 2017 9 / 14
SF-12 are widely used, with fewer ceiling effects and a greater breadth to cover mental health
dimensions as advantages of the SF-12 [33].
How does the diabetes-related trend in HRQOL shown in this longitudinal study compare
with data from cross-sectional analysis? Our previous cross-sectional analysis of baseline data
from the same studies as those analyzed here found a PCS decrease of less than 2 points per
age decade, both for people without diabetes and, at a lower starting position, for people with
prevalent diabetes [3]. However, our present longitudinal analysis shows a much faster decline
in PCS in people with prevalent diabetes (about 5 points over 10 years) because we follow indi-
vidual trajectories of prevalent and incident diabetes cases in a longitudinal perspective.
For MCS in cross-sectional analysis, there is no decline in the age groups 45–74 years, nei-
ther for people with diabetes nor for those without diabetes [3]. This longitudinal analysis
shows a decline in MCS over time, which is statistically significant only for people with preva-
lent diabetes. Arguably, as the age groups included in our study now go beyond 74 years (max-
imum follow-up time was 14 years), a decline in MCS scores may be more visible than in
studies that do not include very old people [34].
A longitudinal study of a practice-based diabetes sample on predictors of change in
HRQOL, which also used PCS and MCS scores as outcome variables [15], found age, smoking,
diabetes complications, and BMI associated with PCS decline. For a decline in MCS, diabetes
complications and self-reported diagnosis of depression were identified as associated with
HRQOL changes. In our analysis living alone was the only risk factor associated with both PCS
and MCS scores. Interestingly, the effects were reversed, negative for PCS and positive for
MCS. Further studies of a broader set of variables measuring functional and psychological
well-being in relation to chronic disease, living arrangements and social support are needed
[35].
Likewise, in other studies including our own cross-sectional study, the diabetes effect on
MCS scores was more pronounced in women than in men [36]. In a longitudinal perspective,
however, no gender difference was found with regard to PCS or MCS scores.
Some limitations of this analysis have to be discussed. First, with only two measurement
points, an analysis of longitudinal change gives less stable results than with multiple waves of
data [37]. Follow-up duration, which in our study extended from 5 to 12 years for the different
cohorts, has an influence on the estimation of annual change and on the comparability of inci-
dent cases. We therefore adjusted all our analyses for study cohort. Although all four cohorts
draw on representative samples to the respective region (or across Germany, as in the case of
the GNHIES98/DEGS1 studies), our data is affected by selection bias. Surveys tend to under-
represent very wealthy and very poor segments of the population as well as institutionalized
people [38], possibly for those with diabetes and for those without diabetes. People who died
between baseline and follow-up were regarded in the same way as drop-outs due to other
causes. This may introduce a healthy survivor bias to our results. Moreover, ill health often
leads to study drop-out and may affect those with diabetes more. Thus, effect sizes between the
groups in our study may be underestimated.
Most data used here draw on self-report. The classification of diabetes, risk factors, and
comorbidities was based upon self-report rather than clinical measures (with the exception of
BMI which was measured at the study center). Studies have shown that the misclassification
error due to self-reported information on such variables is relatively small [39, 40]. Because of
the restrictions of a commonly defined data pool, information on diabetes complications as
well as other comorbidities such as depression, which contribute to overall health burden,
were not collected across all studies and thus could not be analyzed. Studies also used different
versions of the SF12/SF36, thus our analysis relies on the comparability of the summary scores
as assured in the scoring manual [27].
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Our objective was the comparison of HRQOL in people with and without diabetes. For this
task, only a generic HRQOL instrument such as the validated and widely used SF-36/12 should
be used. However, the diabetes burden can only be partly captured by generic HRQOL instru-
ments and needs to be augmented by studies with diabetes-specific instruments [41, 42]. Fur-
ther studies of individual trajectories in HRQOL over time as well as benchmarks for the
interpretation of score differences are needed [37, 43].
In conclusion, we provide important longitudinal data to estimate the incremental burden
of diabetes with a validated instrument and a large pooled dataset combining individual data
from four population-based cohort studies. Studies were similar regarding study design and
sampling frame, providing a population-based reference. Our analysis indicates that the diabe-
tes-associated loss in HRQOL is much larger in the longitudinal perspective than assumed
from cross-sectional analysis. Therefore, efforts to improve diabetes management, including
evidence based treatment and advice for self-management, are key to alleviate the diabetes bur-
den to afflicted patients.
Supporting information
S1 File. Survey questions.
(DOC)
Acknowledgments
This work was supported by "Kompetenznetz Diabetes mellitus (Competence Network for
Diabetes mellitus)" funded by the German Federal Ministry of Education and Research (FKZ
01GI1110E).
The KORA research platform (KORA, Cooperative Research in the Region of Augsburg)
was initiated and financed by the Helmholtz Zentrum München–German Research Center for
Environmental Health, which is funded by the German Federal Ministry of Education and
Research and by the State of Bavaria. The Helmholtz Zentrum München is a member of the
German Center for Diabetes Research. The CARLA study was funded by a grant from the
Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 "Heart fail-
ure in the elderly–cellular mechanisms and therapy" at the Medical Faculty of the Martin-
Luther-University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the
Martin-Luther-University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs
of Saxony-Anhalt, and by the Federal Employment Office. The SHIP is part of the Community
Medicine Research net (http://www.community-medicine.de) at the University of Greifswald,
Germany. Funding was provided by grants from the German Federal Ministry of Education
and Research (BMBF, grant 01ZZ0403), the Ministry for Education, Research and Cultural
Affairs, and the Ministry for Social Affairs of the Federal State of Mecklenburg–West Pomera-
nia. The German National Health Interview and Examination Survey (GNHIES98) and follow-
up study DEGS1 were funded by the German Ministry of Health.
Author Contributions
Conceptualization: MS RH.
Data curation: MS PR RH CSN UE AK SS HV.
Formal analysis: PR MS.
Funding acquisition: RH CM AP.
Longitudinal change of HRQOL in type 2 diabetes
PLOS ONE | https://doi.org/10.1371/journal.pone.0176895 May 3, 2017 11 / 14
Investigation: MS PR RH.
Methodology: PR MS RH.
Project administration: MS RH.
Resources: RH CM AP CSN UE AK SS HV.
Software: PR MS IMRE TT.
Supervision: RH.
Validation: MS IMRE TT SS SH.
Visualization: MS PR.
Writing – original draft: MS RH.
Writing – review & editing: PR IMRE TT SS CSN HV UE AK SH CM AP.
References
1. Grandy S, Fox KM. EQ-5D visual analog scale and utility index values in individuals with diabetes and
at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk
factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes. 2008; 6:18. https://doi.org/10.1186/
1477-7525-6-18 PMID: 18304340
2. Tapp RJ, Dunstan DW, Phillips P, Tonkin A, Zimmet PZ, Shaw JE. Association between impaired glu-
cose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study. Dia-
betes Res Clin Pract. 2006; 74(2):154–61. https://doi.org/10.1016/j.diabres.2006.03.012 PMID:
16740334
3. Schunk M, Reitmeir P, Schipf S, Volzke H, Meisinger C, Thorand B, et al. Health-related quality of life in
subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Ger-
many. Diabet Med. 2012; 29(5):646–53. https://doi.org/10.1111/j.1464-5491.2011.03465.x PMID:
21978176
4. Grandy S, Chapman RH, Fox KM. Quality of life and depression of people living with type 2 diabetes
mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early
evaluation and management of risk factors Leading to Diabetes (SHIELD). Int J Clin Pract. 2008; 62
(4):562–8. https://doi.org/10.1111/j.1742-1241.2008.01703.x PMID: 18266708
5. Chittleborough CR, Baldock KL, Taylor AW, Phillips PJ. Health status assessed by the SF-36 along the
diabetes continuum in an Australian population. Qual Life Res. 2006; 15(4):687–94. https://doi.org/10.
1007/s11136-005-3570-8 PMID: 16688501
6. Alonso J, Ferrer M, Gandek B, Ware JE Jr., Aaronson NK, Mosconi P, et al. Health-related quality of life
associated with chronic conditions in eight countries: results from the International Quality of Life
Assessment (IQOLA) Project. Qual Life Res. 2004; 13(2):283–98. https://doi.org/10.1023/B:QURE.
0000018476.11278.35 PMID: 15085901
7. Ware JE Jr, Snow KK, Kosinski M, B G. SF-36 Health Survey Manual and Interpretation Guide. Boston,
MA: The Health Institute, New England Medical Center; 1993.
8. Wee HL, Cheung YB, Li SC, Fong KY, Thumboo J. The impact of diabetes mellitus and other chronic
medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?
Health Qual Life Outcomes. 2005; 3:2. https://doi.org/10.1186/1477-7525-3-2 PMID: 15644146
9. Hunger M, Thorand B, Schunk M, Doring A, Menn P, Peters A, et al. Multimorbidity and health-related
quality of life in the older population: results from the German KORA-age study. Health Qual Life Out-
comes. 2011; 9:53. https://doi.org/10.1186/1477-7525-9-53 PMID: 21767362
10. Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer JB, et al. Which chronic conditions
are associated with better or poorer quality of life? J Clin Epidemiol. 2000; 53(9):895–907. PMID:
11004416
11. Jayasinghe UW, Proudfoot J, Barton CA, Amoroso C, Holton C, Davies GP, et al. Quality of life of Aus-
tralian chronically-ill adults: patient and practice characteristics matter. Health Qual Life Outcomes.
2009; 7:50. https://doi.org/10.1186/1477-7525-7-50 PMID: 19493336
Longitudinal change of HRQOL in type 2 diabetes
PLOS ONE | https://doi.org/10.1371/journal.pone.0176895 May 3, 2017 12 / 14
12. Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes
and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005; 14(5):1311–
20. PMID: 16047506
13. Grandy S, Fox KM, Group SS. Change in health status (EQ-5D) over 5 years among individuals with
and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health Qual Life Outcomes.
2012; 10:99. https://doi.org/10.1186/1477-7525-10-99 PMID: 22917219
14. Bayliss EA, Bayliss MS, Ware JE Jr., Steiner JF. Predicting declines in physical function in persons with
multiple chronic medical conditions: what we can learn from the medical problem list. Health Qual Life
Outcomes. 2004; 2:47. https://doi.org/10.1186/1477-7525-2-47 PMID: 15353000
15. Maatouk I, Wild B, Wesche D, Herzog W, Raum E, Muller H, et al. Temporal predictors of health-related
quality of life in elderly people with diabetes: results of a German cohort study. PloS one. 2012; 7(1):
e31088. https://doi.org/10.1371/journal.pone.0031088 PMID: 22292092
16. Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, et al. Incidence of Type 2 diabetes
in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort
study. Diabet Med. 2009; 26(12):1212–9. https://doi.org/10.1111/j.1464-5491.2009.02863.x PMID:
20002472
17. Scheidt-Nave C, Kamtsiuris P, Gosswald A, Holling H, Lange M, Busch MA, et al. German health inter-
view and examination survey for adults (DEGS)—design, objectives and implementation of the first
data collection wave. BMC Public Health. 2012; 12:730. https://doi.org/10.1186/1471-2458-12-730
PMID: 22938722
18. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health
in Pomerania. Int J Epidemiol. 2011; 40(2):294–307. https://doi.org/10.1093/ije/dyp394 PMID:
20167617
19. Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, Kuss O, et al. Cardiovascular disease, risk
factors and heart rate variability in the elderly general population: design and objectives of the CARdio-
vascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord. 2005; 5:33.
https://doi.org/10.1186/1471-2261-5-33 PMID: 16283930
20. Jacobi F, Wittchen HU, Holting C, Sommer S, Lieb R, Hofler M, et al. Estimating the prevalence of men-
tal and somatic disorders in the community: aims and methods of the German National Health Interview
and Examination Survey. International journal of methods in psychiatric research. 2002; 11(1):1–18.
PMID: 12459800
21. Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, et al. [The first wave of
the German Health Interview and Examination Survey for Adults (DEGS1): sample design, response,
weighting and representativeness]. Bundesgesundheitsblatt Gesundheitsforschung Gesund-
heitsschutz. 2013; 56(5–6):620–30. https://doi.org/10.1007/s00103-012-1650-9 PMID: 23703478
22. Thefeld W, Stolzenberg H, Bellach BM. [The Federal Health Survey: response, composition of partici-
pants and non-responder analysis]. Gesundheitswesen. 1999; 61 Spec No:S57-61.
23. Bullinger M, Kirchberger I, Ware J. Der deutsche SF-36 Health Survey. Übersetzung und psychome-
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